Friday, December 13, 2024 8:13:17 PM
Recent ALRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2025 09:06:34 PM
- Aileron Therapeutics Announces Rebranding to Rein Therapeutics • PR Newswire (US) • 01/10/2025 04:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2024 09:09:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 09:41:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 09:38:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 09:35:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2024 09:05:08 PM
- Aileron Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights • PR Newswire (US) • 11/14/2024 09:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:03:30 PM
- Aileron Therapeutics Announces Positive Topline Data from Cohort 2 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) • PR Newswire (US) • 11/13/2024 12:00:00 PM
- Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma • PR Newswire (US) • 10/31/2024 11:30:00 AM
- Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lung and Airway Fibrosis • PR Newswire (US) • 10/12/2024 01:00:00 PM
- Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) • PR Newswire (US) • 09/23/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 08:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 08:06:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 08:06:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:17:00 PM
- Aileron Therapeutics to Present at the 8th Annual IPF Summit • PR Newswire (US) • 08/19/2024 08:05:00 PM
- Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights • PR Newswire (US) • 08/14/2024 10:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:23:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 09:12:55 PM
- Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference • PR Newswire (US) • 07/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:36:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 08:33:11 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 08:29:40 PM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM